Path of Exile 2's long path to 1.0 is finally winding down. On Thursday, developer Grinding Gear Games held a digital livestream detailing the latest patch (0.5, "Return of the Ancients"), during ...

On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) announced “a new pathway designed to expedite access to certain FDA-designated Class II ...

Enshrouded’s Forging the Path update delivers its biggest overhaul yet, refining combat, progression, and systems ahead of the 1.0 launch. When Enshrouded launched into Early Access in January 2024, ...

President Trump's Executive Order (EO) seeks to "accelerate innovative research models and appropriate drug approvals to increase access to psychedelic drugs that could save lives and reverse the ...

TORONTO, April 20, 2026 (GLOBE NEWSWIRE)-- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) ("PharmAla" or the "Company"), a global leader in the research, development and manufacturing of ...

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer, a leading healthcare AI company, today announced that the Centers for Medicare & Medicaid Services (CMS) has accepted its application under Story Health ...

Threat actors are now abusing DNS queries as part of ClickFix social engineering attacks to deliver malware, making this the first known use of DNS as a channel in these campaigns. ClickFix attacks ...

Judge orders Fulton County to release 2020 election ballots and records to the Georgia State Election Board. Georgia State Election Board reopened its investigation into Fulton County’s 2020 election ...

New research out today from cybersecurity company watchTowr Pte. Ltd. details a new class of vulnerabilities in the .NET Framework that can allow attackers to weaponize standard SOAP client proxies ...

Pour one out for the ancient MetroCard and its equally old cousin, the PATH SmartLink card. The beginning of the end for these longtime ways to pay fares on the bi-state PATH system came Thursday when ...

Japan continues to position itself as a global leader in regenerative medicine through its progressive regulatory framework tailored to the unique characteristics of cell, tissue, and gene therapy ...